Slew of House Democrats urge FDA, HHS to preserve access to misoprostol, methotrexate
More than 50 House Democrats are calling on the FDA, HHS and the Office for Civil Rights to protect access to misoprostol and methotrexate, which the lawmakers say has been hard for some patients to access in the wake of the Supreme Court’s decision to reverse Roe v. Wade.
The letter — led by representatives Nikki Budzinski (IL), Sean Casten (IL), Becca Balint (AL), Valerie Foushee (NC) and Jill Tokuda (HI) — explains that methotrexate is critical for patients with rheumatoid arthritis and other autoimmune disorders, and can be used to treat ectopic pregnancies in its injectable form.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.